VAERS 2643064
MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015686
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2023
- Impfdatum
- -
- Beginn
- 06.06.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
No adverse event; HCP calling to report an AE regarding the VARIVAX vaccine. HCP reported that the patient received an expired dose of VARIVAX. Request case 02402383 filed. Permission was provided to contact the HCP. No additional AE/PQC reported.; This spontaneous report was received from Consumer and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, lot #U015686, expiration date: 18-MAY-2023 (strength, route of administration, and indication were not provided). On 06-JUN-2023, HCP called to report an AE regarding the varicella virus vaccine live (oka/merck) (VARIVAX) vaccine. HCP reported that the patient received an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX). Request case 02402383 filed. Permission was provided to contact the HCP. No additional AE/PQC reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -